| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2020.03.007 |
| P698 | PubMed publication ID | 32284273 |
| P2093 | author name string | Timothy E Adams | |
| Stephen A Locarnini | |||
| Morten Thaysen-Andersen | |||
| Hans J Netter | |||
| Renae Walsh | |||
| George Lovrecz | |||
| Peter Smooker | |||
| Sayantani Chatterjee | |||
| Carina C D Joe | |||
| P2860 | cites work | Hepatitis B virus morphogenesis | Q24563883 |
| Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
| Advances in aluminum hydroxide-based adjuvant research and its mechanism | Q27007659 | ||
| Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes | Q27469889 | ||
| A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield | Q27675032 | ||
| Molecular biology of hepatitis B virus infection | Q28083478 | ||
| The mannose receptor is a pattern recognition receptor involved in host defense | Q28266161 | ||
| The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism | Q28346519 | ||
| The structure of hepatitis B surface antigen and its antigenic sites | Q69001209 | ||
| Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome | Q81925149 | ||
| Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response | Q82910116 | ||
| RTS,S malaria vaccine pilots in three African countries | Q91602303 | ||
| Post-Column Make-Up Flow (PCMF) Enhances the Performance of Capillary-Flow PGC-LC-MS/MS-Based Glycomics | Q91955169 | ||
| Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: A biomarker for functional cure | Q92399449 | ||
| Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms | Q92881172 | ||
| Subviral particle as vaccine and vaccine platform | Q33812653 | ||
| Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. | Q33967039 | ||
| Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial | Q34043843 | ||
| Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies | Q34059278 | ||
| Hepatitis B small surface antigen particles are octahedral | Q34078427 | ||
| Symbol Nomenclature for Graphical Representations of Glycans | Q34500799 | ||
| Mannose receptor-mediated gene delivery into antigen presenting dendritic cells. | Q35140231 | ||
| Mannosylation of virus-like particles enhances internalization by antigen presenting cells | Q35224806 | ||
| Assembly, structure, and antigenic properties of virus-like particles rich in HIV-1 envelope gp120. | Q35700066 | ||
| Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity. | Q36281860 | ||
| Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans | Q36402805 | ||
| Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. | Q36983584 | ||
| Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children | Q37130595 | ||
| Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012 | Q37214705 | ||
| C-type lectins on dendritic cells: key modulators for the induction of immune responses | Q37330499 | ||
| Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives | Q37494846 | ||
| Lectins as pattern recognition molecules: the effects of epitope density in innate immunity | Q37638925 | ||
| Adaptive immune activation: glycosylation does matter | Q37663706 | ||
| Maintenance of cell surface glycan density by lectin-glycan interactions: a homeostatic and innate immune regulatory mechanism | Q37765108 | ||
| Relative versus absolute quantitation in disease glycomics. | Q38356585 | ||
| Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines. | Q39051308 | ||
| Transient mammalian cell transfection with polyethylenimine (PEI). | Q39099315 | ||
| Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits | Q39433517 | ||
| Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness | Q39488403 | ||
| Adjuvant formulations for virus-like particle (VLP) based vaccines | Q40093469 | ||
| Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype | Q41752880 | ||
| Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine | Q42986151 | ||
| A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles | Q45009758 | ||
| Nanoparticles target distinct dendritic cell populations according to their size | Q45732404 | ||
| Synthesis and assembly of hepatitis B virus surface antigen particles in yeast | Q45793098 | ||
| Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo | Q46804413 | ||
| A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice | Q47194469 | ||
| A topological model for hepatitis B surface antigen | Q47637820 | ||
| Structural analysis of N- and O-glycans released from glycoproteins. | Q47650166 | ||
| Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particles | Q47808279 | ||
| Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine | Q48004555 | ||
| Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. | Q52000133 | ||
| The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells | Q57275938 | ||
| Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid | Q64381595 | ||
| P921 | main subject | Hepatitis B virus | Q6844 |
| P577 | publication date | 2020-04-10 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity |
Search more.